Disposition of 14553 shares by Autor Deborah M. of Amneal Pharmaceuticals at 6.76 subject to Rule 16b-3

AMRX Stock  USD 8.27  0.08  0.96%   
Slightly above 53% of Amneal Pharmaceuticals,'s investor base is interested to short. The analysis of overall sentiment of trading Amneal Pharmaceuticals, Class stock suggests that many investors are impartial at this time. Amneal Pharmaceuticals,'s investing sentiment can be driven by a variety of factors including economic data, Amneal Pharmaceuticals,'s earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Amneal Pharmaceuticals Class Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 14553 class a common stock at 6.76 of Amneal Pharmaceuticals by Autor Deborah M. on 16th of May 2024. This event was filed by Amneal Pharmaceuticals Class with SEC on 2024-05-16. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Amneal Pharmaceuticals,'s cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Amneal Pharmaceuticals,'s relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Amneal Pharmaceuticals, Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Amneal Pharmaceuticals, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Amneal Pharmaceuticals, Historical Investor Sentiment

Investor biases related to Amneal Pharmaceuticals,'s public news can be used to forecast risks associated with an investment in Amneal. The trend in average sentiment can be used to explain how an investor holding Amneal can time the market purely based on public headlines and social activities around Amneal Pharmaceuticals, Class. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amneal Pharmaceuticals,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amneal Pharmaceuticals, and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Amneal Pharmaceuticals, news discussions. The higher the estimate score, the more favorable the investor's outlook on Amneal Pharmaceuticals,.

Amneal Pharmaceuticals, Fundamental Analysis

We analyze Amneal Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amneal Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amneal Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Revenue

Revenue Comparative Analysis

Amneal Pharmaceuticals, is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Amneal Pharmaceuticals, Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amneal Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of Amneal Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing Amneal Pharmaceuticals, by comparing valuation metrics with similar companies.

Peers

Amneal Pharmaceuticals, Related Equities

ASRTAssertio Therapeutics   2.04   
0%
7.0%
NBIXNeurocrine Biosciences   0.13   
0%
1.0%
AMPHAmphastar   0.04   
1.0%
0%
DVAXDynavax Technologies   0.39   
1.0%
0%
COLLCollegium Pharmaceutical   0.68   
2.0%
0%
EOLSEvolus   0.80   
2.0%
0%
PAHCPhibro Animal   0.93   
3.0%
0%
ALKSAlkermes Plc   1.02   
3.0%
0%
ITCIIntracellular   1.09   
3.0%
0%
LFCRLifecore Biomedical   1.20   
4.0%
0%
ANIPANI Pharmaceuticals   3.64   
13.0%
0%
IRWDIronwood Pharmaceuticals   4.09   
14.0%
0%
PROCProcaps Group   27.75   
100.0%
0%

Additional Tools for Amneal Stock Analysis

When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.